October 11, 2023
Researchers at UC San Diego and the Icahn School of Medicine at Mount Sinai have been awarded an $8.5 million grant to create a data integration hub aimed at accelerating novel therapeutics and cures for diseases within initiatives supported by the NIH Common Fund.
June 15, 2017
University of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover meaningful treatments for metabolic diseases.
March 29, 2016
To understand how people can live longer throughout the world, researchers at University of California, San Diego School of Medicine have teamed up with colleagues at University of Rome La Sapienza to study a group of 300 citizens, all over 100 years old, living in a remote Italian village nestled…
May 1, 2014
…for genetic, proteomic (protein-related), metabolomic and molecular markers of the effects of – and adaptations to – space flight. The standard stay on the space station is approximately six months. No human has ever lived in space for an entire year. For those who still dream of manned space explorations…
July 29, 2015
Tapping the potential of metabolomics, an emerging field focused on the chemical processes of metabolism, researchers at University of California, San Diego School of Medicine have identified a new and pivotal player in diabetic kidney disease.
November 2, 2015
Researchers at the University of California, San Diego have developed a model that could be used to predict a drug’s side effects on different patients. The proof of concept study is aimed at determining how different individuals will respond to a drug treatment and could help assess whether a drug…
July 2, 2019
Bladder cancer, one of the most common cancers in the U.S., may be soon helped by a novel non-invasive diagnostic method thanks to machine learning research by researchers at UC San Diego’s San Diego Supercomputer Center and Moores Cancer Center.
December 1, 2020
A team of SDSC researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19
October 19, 2017
University of California San Diego researchers have developed the first 3D spatial visualization tool for mapping “’omics” data onto whole organs. The tool helps researchers and clinicians understand the effects of chemicals, such as microbial metabolites and medications, on a diseased organ in the context of microbes that also inhabit…
May 10, 2024
New insights into the metabolism of autism from researchers at UC San Diego could help inform early detection and prevention strategies for the disorder.
